Summary: Barclays Capital Inc. Series 2011-10B; Residual Certificates; Tender Option Certificates/Bonds Feb 11

  • ID: 2087094
  • February 2011
  • Standard & Poors
1 of 3


  • Barclays Capital Inc.
  • Wisconsin
  • MORE

Standard & Poor's Ratings Services assigned its 'AA-/A-1+' and 'AA-' ratings to Barclays Capital Inc.'s floating rate trust receipts and residual interest trust receipts, respectively, series 2011-10B, relating to Wisconsin's general fund annual appropriation bonds series 2009A. The long-term component of the rating is based on the underlying bonds. The short-term component of the rating is based on Barclays Bank PLC, until Feb. 1, 2012. USPF Criteria: Secondary Market Derivative Products, June 27, 2007...

Companies mentioned in this report are:
- Wisconsin
- Barclays Capital Inc.

Action: New Rating

Standard and Poors RatingsXpress Credit Research provides in-depth coverage of international corporates, financial institutions, insurance companies, utilities, sovereigns and structured finance programs. RatingsXpress Credit Research lets users determine the credit rating of holdings and identify key factors underlying an issuer's creditworthiness, distinguishes the different risk exposures for new and existing deals, and provides an understanding of how their analysts interpret key regulatory, political and environmental events and their economic impact.

This product consists of a Summary Analysis: Bi-annual (at least). An abbreviated analysis containing Standard & Poor's issuer credit ratings as of the time the article was published. The analysis includes a rating rationale - the basis on which the rating was assigned - and an outlook section if the issuer is not on CreditWatch. Financial statistics are not included.

Note: Product cover images may vary from those shown
2 of 3

- Wisconsin
- Barclays Capital Inc.

Note: Product cover images may vary from those shown
3 of 3
Note: Product cover images may vary from those shown




Our Clients

  • Fluidigm Corporation
  • Apple, Inc.
  • CEVA Santé Animale
  • Abbott Laboratories Ltd.
  • Merck Group
  • Allergan Inc.
  • Pfizer Inc.